We are very pleased to welcome Claudia Fromond to Vect-Horus as our new Director of R&D.
Claudia is a highly regarded pharmacology and translational science leader with extensive experience in R&D. She has successfully overseen first-in-class programs from discovery to Investigational New Drug (IND) application and early clinical development, including a portfolio of seven IND-enabling programs which achieved Phase 1/2 readiness.
“Claudia has a proven track record of successfully managing R&D projects and shaping R&D strategy across numerous modalities. I am confident that her expertise and vision will be key to advancing our technology and expanding our external collaborations,” said Alexandre Tokay, co-founder and CEO of Vect-Horus.